权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Plasmodium vivax Erythrocyte Invasion Mechanisms and Humoral Immune Response in Duffy Negative Africans

达菲阴性非洲人间日疟原虫红细胞侵袭机制和体液免疫反应

基本信息

批准号：
10445540
负责人：
Eugenia Lo
金额：
$ 67.36万
依托单位：
UNIVERSITY OF NORTH CAROLINA CHARLOTTE
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-02-09 至 2027-01-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10445540
关键词：
Africa African African ancestry Age Antibodies Antibody Response Antigens Binding Binding Proteins Biochemical Biological Assay Candidate Disease Gene Case Study Cells Copy Number Polymorphism DNA Data Diagnosis Disease Enrollment Epidemic Erythrocytes Ethiopia Flow Cytometry Foundations Gender Gene Dosage Gene Expression Genes Genetic Genetic Transcription Genotype Health Immune response Immunize Immunoassay Immunoglobulin G In Vitro Individual Infection Invaded Knowledge Ligand Binding Ligands Logistics Malaria Measures Molecular Mutation Oryctolagus cuniculus Outcome Parasites Patients Phenotype Plasma Plasmids Plasmodium vivax Plasmodium vivax vaccine Population Process Proteins Public Health RNA Recombinant Proteins Reporting Research Reticulocytes Risk Assessment Sampling Site Surface Time Variant Vivax Malaria Whole Blood antigen binding base comparative density differential expression feasibility research gene cloning genomic signature in vivo inhibiting antibody parasite invasion receptor residence sample collection transcriptome transcriptome sequencing vaccine development vector

项目摘要

PROJECT SUMMARY Title: Plasmodium vivax Erythrocyte Invasion Mechanisms and Humoral Immune Response in Duffy Negative Africans Individuals of African ancestry were thought to be protected from Plasmodium vivax because they lack Duffy antigen expression on the surface of their erythrocytes rendering P. vivax unable to invade their red blood cells. However, an increasing number of P. vivax cases reported across Africa and in Duffy-negative individuals challenges this conventional dogma, raising the possibility that some P. vivax lineages have evolved to use ligands other than Duffy Binding Protein for erythrocyte invasion. The intrinsic invasion mechanism and immune response of Duffy-negative individuals to P. vivax are largely unknown. In this application, we will investigate the expression and function of erythrocyte binding genes in Duffy-negative P. vivax and the antibody response of Duffy-negative individuals to P. vivax antigens. There are three specific aims: 1) to identify genes with differential expression between Duffy-positive and Duffy-negative P. vivax by RNA-seq; 2) to determine in vitro binding and invasion activities of P. vivax candidate ligand proteins to Duffy-negative red blood cells; and 3) to examine in vivo antibody levels to targeted P. vivax antigens associated with erythrocyte invasion in Duffy- negative patients. The proposed research will be conducted in Ethiopia, where malaria is a major public health problem and about 30% of the 1.2 million confirmed malaria cases were P. vivax. As our study sites have a large number of P. vivax cases and a significant proportion of Duffy-negative individuals, we have a unique opportunity to study the invasion mechanisms of P. vivax in Africa. We have a collaborative team and logistics in place for sample collection and processing. Our established lab culture facility closes to the health centers and successful P. vivax transcriptome data obtained from cultured schizonts have demonstrated the feasibility of this research. Comparison of P. vivax transcriptomes between Duffy-negative and Duffy-positive individuals from both in vitro and in vivo samples will provide the first description of genetic and functional attributes of P. vivax that permit infection of Duffy-negative erythrocytes. This research will significantly enhance the understanding of invasion mechanism of P. vivax in Duffy- negative individuals and lay a foundation for molecular and biochemical characterizations of P. vivax ligand-receptor interactions. Knowledge of P. vivax invasion mechanisms and host immune responses will have important implications for P. vivax vaccine development and vivax malaria risk assessment both within and outside Africa.

项目总结